Afeyan’s Moderna COVID-19 Vaccine To Start Final Testing Stage In July
Friday, June 12, 2020Afeyan’s Moderna COVID-19 Vaccine To Start Final Testing Stage In July
Moderna on Thursday confirmed it plans to start a trial of 30,000 volunteers of its much-anticipated coronavirus vaccine in July as the company enters the final stage of testing.
-
The Cambridge, Massachusetts-based biotech said the primary goal of the study would be to prevent symptomatic Covid-19, the disease caused by the novel coronavirus. The key secondary goal would be prevention of severe disease, as defined by keeping people out of the hospital.
-
Moderna said it has selected the 100 microgram dose of the vaccine for the late-stage study. At that dose level, the company is on track to deliver about 500 million doses per year, and possibly up to 1 billion doses per year, starting in 2021 from the company’s internal U.S. manufacturing site and strategic collaboration with Swiss drugmaker Lonza.